Shuttle Pharmaceuticals announces 25-for-1 proposed reverse stock split

Shuttle Pharmaceuticals (SHPH) announces that its Board of Directors have approved a proposed reverse stock split of its common stock at a ratio of 25-for-1. The proposed action remains subject to approval by Nasdaq and, if approved, the Company will issue a subsequent announcement disclosing the effective date.